Tomorrow Accelerated.

Artis BioSolutions is advancing products and services that streamline the discovery, development, and production of genetic medicines and biologics.

The Art and Science of Artis

Our mission is to accelerate tomorrow’s discoveries, tomorrow’s medicines and tomorrow’s cures through innovative technology, unmatched know-how and a scalable approach. At Artis, we apply our founders experience launching and scaling critical products and technologies to streamline a path to commercialization for our customers.

Tech

Technology Expertise

At Artis BioSolutions, our solutions are designed to simplify complexity and accelerate therapeutic development, enabling researchers and developers to go from concept to clinic faster than ever before.

We specialize in cutting-edge technologies such as nucleic acids, enzymes, peptides, lipid nanoparticles (LNP), reagents, and analytical development, making us a trusted partner for complex therapeutic initiatives.

Artis supports drug development from Phase 1 trials to commercial readiness.

OPS

Operational Excellence

The Artis team has demonstrated unparalleled operational execution, successfully scaling critical technology for global commercial use, a benchmark in modern biotech.

Leading the deployment of over $250M of capital across seven state-of-the-art clinical to commercial GMP facilities, Artis understands how to support projects of all sizes.

Team

Client-First Approach

The Artis team strives to put our customers’ success first. Our leadership has led organizations in the development of over 50 active pharmaceutical ingredients (APIs) and critical raw materials (CRM) for clinical and commercial programs across broad modalities including cell & gene, mRNA, peptide, and oligonucleotide therapies. We bring this vast experience to tailor our solutions to meet the unique needs of each project, driving efficiencies and increasing the pace of drug discovery and production.

Highly proficient in technology transfer, Artis enables corporate partners and contract manufacturing organizations to successfully commercialize novel products.

Brian Neel

Founder & Chief Executive Officer

Brian brings 25 years of experience in the life science and diagnostic industries to Artis. Brian specializes in leading and optimizing business operations with a history of first-to-market successes. Through his unique ability to develop highly flexible teams, facilities and capabilities, Brian shifts businesses towards new markets and next-generation platforms - underscoring Artis' capability to expand and innovate without compromising efficiency.

Mike Houston, Ph.D.

Founder & Chief Scientific Officer

Mike holds a Ph.D. in bioorganic chemistry and has led scientific operations and strategies across biotechnology and pharmaceutical companies. Mike specializes in oligonucleotide, protein/ peptide/lipid nanoparticle-based drug products & delivery formulations and analytical development - setting new standards for quality and compliance in genomic medicine.

Our Leadership

Artis BioSolutions' founding team brings over 50 years combined experience, delivering pioneering technologies that achieve unprecedented commercial success.

Partnering With Artis

Artis BioSolutions is a growth equity company that creates unprecedented value for their partners. A proven accelerator, Artis enables small to mid-size businesses to scale or expand reach by providing unparalleled expertise, capital support and access to a network of experts. Artis is actively seeking partners with innovative platforms or capabilities that will catalyze success for Advanced Therapy Medicinal Product developers.

Contact us today if you are a founder-led company in North America or Europe with a shared mission to advance next-generation therapies.

Get in Touch

"*" indicates required fields